These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8516492)

  • 1. Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implications.
    Bellotti V; Stoppini M; Perfetti V; Zorzoli I; Marinone G; Maggi A; Invernizzi R; Arbustini E; Merlini G
    Ren Fail; 1993; 15(3):365-71. PubMed ID: 8516492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications.
    Bellotti V; Stoppini M; Perfetti V; Zorzoli I; Marinone G; Invernizzi R; Zambelli LM; Arbustini E; Grasso M; Ferri G
    Scand J Immunol; 1992 Oct; 36(4):607-15. PubMed ID: 1411304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies.
    Perfetti V; Bellotti V; Garini P; Zorzoli I; Rovati B; Marinone MG; Ippoliti G; Merlini G
    Lab Invest; 1994 Dec; 71(6):853-61. PubMed ID: 7807967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.
    Solomon A; Weiss DT; Wall JS
    Cancer Biother Radiopharm; 2003 Dec; 18(6):853-60. PubMed ID: 14969598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
    Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
    Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis.
    Block PJ; Skinner M; Benson MD; Cohen AS
    Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.
    Bai J; Li X; Zhao J; Zong H; Yuan Y; Wang L; Zhang X; Ke Y; Han L; Xu J; Ma B; Zhang B; Zhu J
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.
    Wall JS; Kennel SJ; Paulus M; Gregor J; Richey T; Avenell J; Yap J; Townsend D; Weiss DT; Solomon A
    J Nucl Med; 2006 Dec; 47(12):2016-24. PubMed ID: 17138745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.
    O'Nuallain B; Allen A; Kennel SJ; Weiss DT; Solomon A; Wall JS
    Biochemistry; 2007 Feb; 46(5):1240-7. PubMed ID: 17260953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with AL amyloidosis with negative free light chain results.
    Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
    Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.
    Wall JS; Kennel SJ; Williams A; Richey T; Stuckey A; Huang Y; Macy S; Donnell R; Barbour R; Seubert P; Schenk D
    PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the management of AL Amyloidosis.
    Kastritis E; Dimopoulos MA
    Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antisense approach in amyloid light chain amyloidosis: identification of monoclonal Ig and inhibition of its production by antisense oligonucleotides in in vitro and in vivo models.
    Ohno S; Yoshimoto M; Honda S; Miyachi S; Ishida T; Itoh F; Endo T; Chiba S; Imai K
    J Immunol; 2002 Oct; 169(7):4039-45. PubMed ID: 12244207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain.
    Hoshii Y; Nanbara H; Cui D; Takahashi M; Ikeda E
    Med Mol Morphol; 2012 Jun; 45(3):124-8. PubMed ID: 23001294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis
    Renz M; Torres R; Dolan PJ; Tam SJ; Tapia JR; Li L; Salmans JR; Barbour RM; Shughrue PJ; Nijjar T; Schenk D; Kinney GG; Zago W
    Amyloid; 2016 Sep; 23(3):168-177. PubMed ID: 27494229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.